Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1962 1
1967 1
1973 1
1974 1
1975 1
1976 2
1979 3
1980 3
1981 3
1982 4
1983 2
1984 3
1985 8
1986 7
1987 3
1988 7
1989 4
1990 20
1991 19
1992 23
1993 26
1994 22
1995 20
1996 11
1997 9
1998 15
1999 13
2000 18
2001 12
2002 11
2003 25
2004 19
2005 16
2006 20
2007 26
2008 13
2009 18
2010 22
2011 21
2012 33
2013 31
2014 32
2015 34
2016 39
2017 40
2018 26
2019 29
2020 50
2021 50
2022 55
2023 37
2024 37
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

912 results

Results by year

Filters applied: . Clear all
Page 1
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.
Mesa R, Gill H, Zhang L, Jin J, Kirito K, Komatsu N, Qin A, Xiao Z, Tashi T, Shimoda K, Ohishi K, Chen S, Zuo X, Shirane S, Hu Y, Zhang S, Wang Y, Takenaka K, Ichii M, Xu N, Shih LY, Lim KH, Lee SE, Bae SH, Teo WZY, Maze D, Oh ST, Bose P, Sato T, Zagrijtschuk O, Lin S, Shih WJ, Mascarenhas J, Masarova L; SURPASS-ET Study Group. Mesa R, et al. Among authors: shimoda k. Lancet Haematol. 2025 Nov;12(11):e862-e875. doi: 10.1016/S2352-3026(25)00264-9. Lancet Haematol. 2025. PMID: 41193116 Clinical Trial.
Prognostic value of lymphocyte-to-monocyte ratio in relapsed/refractory adult T-cell Leukemia/lymphoma patients receiving mogamulizumab.
Shimazu Y, Kameda T, Kitawaki T, Kamiunten A, Sekine M, Kawano H, Sato S, Maeda K, Toyama T, Kawano N, Yamashita K, Takeuchi M, Ishizaki J, Shimoda K, Takaori-Kondo A. Shimazu Y, et al. Among authors: shimoda k. Clin Immunol. 2025 Oct 30;282:110616. doi: 10.1016/j.clim.2025.110616. Online ahead of print. Clin Immunol. 2025. PMID: 41175952
Gene expression profiling of airway epithelium in Mycobacterium avium complex lung disease.
Furuuchi K, Hijikata M, Seto S, Miyabayashi A, Wakabayashi K, Nakagawa T, Yoshida T, Shimoda K, Hiramatsu M, Shiraishi Y, Morimoto K, Keicho N. Furuuchi K, et al. Among authors: shimoda k. ERJ Open Res. 2025 Oct 27;11(5):00011-2025. doi: 10.1183/23120541.00011-2025. eCollection 2025 Sep. ERJ Open Res. 2025. PMID: 41158480 Free PMC article.
TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasms.
Tahira Y, Shide K, Kameda T, Uchida T, Kamiunten A, Akizuki K, Kubuki Y, Karasawa M, Ikeda R, Matsumoto K, Bai J, Terashima M, Kato K, Uto T, Fukaya T, Mitoma S, Sato K, Uehira Y, Ueno H, Sashida G, Yamaguchi H, Shimoda K. Tahira Y, et al. Among authors: shimoda k. Blood Neoplasia. 2025 Mar 3;2(3):100087. doi: 10.1016/j.bneo.2025.100087. eCollection 2025 Aug. Blood Neoplasia. 2025. PMID: 40948661 Free PMC article.
912 results